Loading...
DLB logo

Dolby Laboratories, Inc.NYSE:DLB Aktierapport

Marknadsvärde US$4.7b
Aktiekurs
n/a
1Y-34.7%
7D-1.6%
1D-1.7%
Portföljens värde
Utsikt

Dolby Laboratories, Inc.

NYSE:DLB Aktierapport

Börsvärde: US$4.7b

Dolby Laboratories (DLB) Aktievy

Dolby Laboratories, Inc. är verksamt inom design och tillverkning av ljud-, bild-, tillgänglighets- och andra hårdvaru- och mjukvarulösningar för TV-, radio- och liveunderhållningsindustrin i USA och internationellt. Mer information

DLB fundamental analys
Snöflinga Score
Värdering5/6
Framtida tillväxt1/6
Tidigare resultat1/6
Finansiell hälsa6/6
Utdelningar5/6

DLB Community Fair Values

Create Narrative

See what 29 others think this stock is worth. Follow their fair value or set your own to get alerts.

Dolby Laboratories, Inc. Konkurrenter

Prishistorik och prestanda

Sammanfattning av aktiekursernas upp- och nedgångar samt förändringar för Dolby Laboratories
Historiska aktiekurser
Aktuell aktiekursUS$48.51
52 veckors högstaUS$77.00
52 veckors lägstaUS$48.26
Beta0.81
1 månads förändring-7.64%
3 månaders förändring-23.01%
1 års förändring-34.75%
3 års förändring-45.97%
5 års förändring-50.58%
Förändring sedan börsintroduktionen99.63%

Senaste nyheter och uppdateringar

Uppdatering av berättelse Jul 03

DLB: Streaming Partnerships And Buybacks Will Support Future Upside Potential

Analysts have reduced their fair value estimate for Dolby Laboratories from $68.00 to $60.00. They cite more conservative revenue growth assumptions and a lower future P/E multiple, partly offset by slightly stronger projected profit margins and a modestly higher discount rate.
Analysartikel Jun 20

Dolby Laboratories (DLB) Stock Could Be 33.2% Undervalued After Hitting A One Year Low

Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...
Uppdatering av berättelse Jun 18

DLB: World Cup Streaming Deal Will Support Future Share Price Recovery

Analysts have maintained their fair value estimate for Dolby Laboratories at $78.33 per share. Only minor model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions were made, resulting in an unchanged price target.
Uppdatering av berättelse Jun 04

DLB: Immersive Content Partnerships Will Support Future Share Price Recovery

Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.

Recent updates

Uppdatering av berättelse Jul 03

DLB: Streaming Partnerships And Buybacks Will Support Future Upside Potential

Analysts have reduced their fair value estimate for Dolby Laboratories from $68.00 to $60.00. They cite more conservative revenue growth assumptions and a lower future P/E multiple, partly offset by slightly stronger projected profit margins and a modestly higher discount rate.
Analysartikel Jun 20

Dolby Laboratories (DLB) Stock Could Be 33.2% Undervalued After Hitting A One Year Low

Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...
Uppdatering av berättelse Jun 18

DLB: World Cup Streaming Deal Will Support Future Share Price Recovery

Analysts have maintained their fair value estimate for Dolby Laboratories at $78.33 per share. Only minor model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions were made, resulting in an unchanged price target.
Uppdatering av berättelse Jun 04

DLB: Immersive Content Partnerships Will Support Future Share Price Recovery

Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.
Uppdatering av berättelse May 17

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).
Seeking Alpha May 03

Dolby: I Don't Mind Waiting In 2026

Summary Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security. A dividend yield of 2.5%, ongoing buybacks at attractive valuations, and minimal inflation sensitivity further strengthen the investment case. Read the full article on Seeking Alpha
Uppdatering av berättelse May 01

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Uppdatering av berättelse Apr 17

DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside

Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.
Uppdatering av berättelse Apr 03

DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook

Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).
Uppdatering av berättelse Mar 19

DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook

Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.
Uppdatering av berättelse Mar 05

DLB: Media Partnerships And Buybacks Will Support Measured Future Returns

Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
Uppdatering av berättelse Feb 19

DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns

Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.
Uppdatering av berättelse Feb 04

DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions

Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.
Analysartikel Feb 02

Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...
Uppdatering av berättelse Jan 21

DLB: Technology Adoption And Solid Execution Will Support Future Share Gains

Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.
Uppdatering av berättelse Jan 06

DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption

Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.
Analysartikel Jan 05

Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?

Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...
Uppdatering av berättelse Dec 21

DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption

Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.
Uppdatering av berättelse Dec 07

DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds

Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.
Uppdatering av berättelse Nov 23

DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds

Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.
Analysartikel Nov 11

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysartikel Sep 27

Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...
Uppdatering av berättelse Sep 06

Expanding Auto And Device Ecosystems Will Define Immersive Entertainment

Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.
Analysartikel Jul 28

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it had a relatively subdued...
Analysartikel May 27

Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate

Key Insights Dolby Laboratories' estimated fair value is US$112 based on 2 Stage Free Cash Flow to Equity Dolby...
Analysartikel May 06

Should You Be Adding Dolby Laboratories (NYSE:DLB) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysartikel Apr 07

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it received a lot of...
Analysartikel Mar 23

Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Could Signal Some Risk

Dolby Laboratories, Inc.'s ( NYSE:DLB ) price-to-earnings (or "P/E") ratio of 29.6x might make it look like a strong...
Analysartikel Mar 10

Return Trends At Dolby Laboratories (NYSE:DLB) Aren't Appealing

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Seeking Alpha Feb 07

Dolby Laboratories Remains Fully Valued On Slow Growth

Summary Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely. Despite moderate growth expectations and a full stock price valuation, I maintain a Neutral rating on DLB stock due to limited upside potential. Read the full article on Seeking Alpha
Analysartikel Feb 01

Dolby Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Dolby Laboratories, Inc. ( NYSE:DLB ) just released its latest first-quarter results and things are looking bullish...
Analysartikel Jan 26

Are Investors Undervaluing Dolby Laboratories, Inc. (NYSE:DLB) By 38%?

Key Insights The projected fair value for Dolby Laboratories is US$128 based on 2 Stage Free Cash Flow to Equity Dolby...

Aktieägarnas avkastning

DLBUS SoftwareUS Marknad
7D-1.6%-1.4%-0.9%
1Y-34.7%-20.9%19.4%

Avkastning vs industri: DLB presterade sämre än US Software branschen som gav -20.9 % under det senaste året.

Avkastning vs Marknaden: DLB presterade sämre än US marknaden som gav 19.4 % under det senaste året.

Prisvolatilitet

Is DLB's price volatile compared to industry and market?
DLB volatility
DLB Average Weekly Movement4.4%
Software Industry Average Movement10.0%
Market Average Movement7.2%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.2%

Stabil aktiekurs: DLB har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.

Volatilitet över tid: DLB s veckovolatilitet ( 4% ) har varit stabil under det senaste året.

Om företaget

GrundadAnställdaVD OCH KONCERNCHEFWebbplats
19652,051Kevin Yeamanwww.dolby.com

Dolby Laboratories, Inc. är verksamt inom design och tillverkning av ljud-, bild-, tillgänglighets- och andra hårdvaru- och mjukvarulösningar för TV-, radio- och liveunderhållningsindustrin i USA och internationellt. Företaget utvecklar och licensierar sina ljudteknologier, såsom AAC, HE-AAC och utökad HE-AAC, en digital ljudkodeklösning; AVC, en digital videokodek som används i STB, mobila enheter, kameror och TV-tjänster och andra produkter; och Dolby Atmos och Dolby Vision inkluderar kodningsteknologier som artister använder för att skapa mer övertygande och uppslukande ljud- och videoupplevelser. Företaget erbjuder också DD+, en avancerad codec-teknik för surroundljud, Dolby AC-4, en ljudcodec som använder avancerad komprimering, och HEVC, en digital video-codec som komprimerar video.

Dolby Laboratories, Inc. Sammanfattning av grunderna

Hur förhåller sig Dolby Laboratories:s resultat och omsättning till dess börsvärde?
DLB grundläggande statistik
BörsvärdeUS$4.67b
Vinst(TTM)US$243.65m
Intäkter(TTM)US$1.36b
18.8x
P/E-förhållande
3.4x
P/S-förhållande

Resultat & intäkter

Viktig lönsamhetsstatistik från den senaste resultatrapporten (TTM)
DLB resultaträkning (TTM)
IntäkterUS$1.36b
Kostnad för intäkterUS$171.46m
BruttovinstUS$1.19b
Övriga kostnaderUS$949.80m
IntäkterUS$243.65m

Senast redovisade vinst

Mar 27, 2026

Nästa vinstdatum

n/a

Vinst per aktie (EPS)2.58
Bruttomarginal87.44%
Nettovinstmarginal17.85%
Skuld/egenkapitalförhållande0%

Hur har DLB utvecklats på lång sikt?

Se historisk utveckling och jämförelse

Utdelningar

3.0%
Aktuell utdelningsavkastning
55%
Utbetalningskvot

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/07/14 01:17
Aktiekurs vid dagens slut2026/07/14 00:00
Intäkter2026/03/27
Årlig intjäning2025/09/26

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Dolby Laboratories, Inc. bevakas av 13 analytiker. 4 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Vikram KesavabhotlaBaird
Patrick ShollBarrington Research Associates, Inc.
Eric WoldB. Riley Securities, Inc.